Genome wide profiling of histone variants in tumors
肿瘤中组蛋白变异的全基因组分析
基本信息
- 批准号:8938009
- 负责人:
- 金额:$ 36.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressCancer cell lineCentromereChromatin StructureChromosomal InstabilityChromosome Fragile SitesColorectal CancerEpigenetic ProcessFailureFunctional RNAFutureGenesGenomeGoalsHistonesHumanLeadLocationMapsMethodsModificationOutcomePostdoctoral FellowProcessSpecificityVariantWorkcancer cellcentromere protein Afollow-upgenome-widenew technologyresponsetumortumor progressiontumorigenic
项目摘要
We have mapped unique histone variant genome wide in colorectal cancer cell lines and found that that they cluster at a subset of epigenetically distinctive regions. We have mapped these regions further using cytological methods and discovered a new centromere-like region in a fragile chromosome site encompassing the myc locus. Future goals involve mapping histone variants in tumors in order to track progression of aberrant chromatin structures as a consequence of the tumorigenic process, and discovering remodelers and processes involved in the mis-localization. We are also purifying large quantities of histone variants and examining their modification status in response to tumor progression.
我们已经在结直肠癌细胞系中绘制了独特的组蛋白变体基因组,并发现它们聚集在表观遗传学独特区域的子集上。我们已经绘制了这些地区进一步使用细胞学方法,并发现了一个新的着丝粒样的区域在一个脆弱的染色体站点包括myc基因座。未来的目标包括绘制肿瘤中的组蛋白变体,以跟踪肿瘤发生过程导致的异常染色质结构的进展,并发现错误定位中涉及的重塑和过程。我们还纯化了大量的组蛋白变体,并检查了它们对肿瘤进展的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMINI P DALAL其他文献
YAMINI P DALAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMINI P DALAL', 18)}}的其他基金
Analysis of centromere identity and structure in human cells
人类细胞着丝粒的身份和结构分析
- 批准号:
7966218 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Analysis of centromere identity and structure in human cells
人类细胞着丝粒的身份和结构分析
- 批准号:
8553040 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Analysis of centromere identity and structure in human cells
人类细胞着丝粒的身份和结构分析
- 批准号:
10014571 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Kinetochore Interaction with Centromere Chromatin in human cells
着丝粒与人体细胞中着丝粒染色质的相互作用
- 批准号:
8157701 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Biomechanical properties of chromatin in cancer and normal cells
癌症和正常细胞染色质的生物力学特性
- 批准号:
10702505 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Genome wide profiling of histone variants in colorectal cancer cells
结直肠癌细胞组蛋白变异的全基因组分析
- 批准号:
8349395 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Genome wide profiling of histone variants in tumors
肿瘤中组蛋白变异的全基因组分析
- 批准号:
10014570 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Analysis of centromere identity and structure in human cells
人类细胞着丝粒的身份和结构分析
- 批准号:
10262264 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
Genome wide profiling of histone variants in colorectal cancer cells
结直肠癌细胞组蛋白变异的全基因组分析
- 批准号:
7966216 - 财政年份:
- 资助金额:
$ 36.81万 - 项目类别:
相似海外基金
Drug resistance and calcium signaling in cancer cell line
癌细胞系中的耐药性和钙信号传导
- 批准号:
20K16338 - 财政年份:2020
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identification of novel target molecules involved in spontaneous bone metastasis of mouse breast cancer cell line.
鉴定参与小鼠乳腺癌细胞系自发骨转移的新靶分子。
- 批准号:
17K07159 - 财政年份:2017
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Differential expression of cell adhesion molecule of CD133-positive / negative cells derived from oral cancer cell line and diagnostic treatment targeting it
口腔癌细胞系CD133阳性/阴性细胞细胞粘附分子的差异表达及针对其的诊断治疗
- 批准号:
17K17251 - 财政年份:2017
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Two types of monoclonal antibodies generated by immunizing mice with MIA-PaCa-2 human pancreatic cancer cell line for diagnostic and therapeutic strategies for pancreatic cancer
用 MIA-PaCa-2 人胰腺癌细胞系免疫小鼠产生两种类型的单克隆抗体,用于胰腺癌的诊断和治疗策略
- 批准号:
16K10595 - 财政年份:2016
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Metabolome analysis of invaded pancreatic cancer cell line, PANC-1, after irradiation
照射后侵袭性胰腺癌细胞系 PANC-1 的代谢组分析
- 批准号:
25461934 - 财政年份:2013
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proteomics analysis of cancer stem cell and its microenvironment using FFPE tissue and cancer cell line
使用 FFPE 组织和癌细胞系对癌症干细胞及其微环境进行蛋白质组学分析
- 批准号:
25710013 - 财政年份:2013
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Autophagy is involved in a clearance of anti-cancer agent doxorubicin in the multidrug resistant cancer cell line.
自噬参与多药耐药癌细胞系中抗癌药物阿霉素的清除。
- 批准号:
25670083 - 财政年份:2013
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
An attempt to identify new antigens recognized by tumor-specific cytotoxic T lymphocytes using a HLA-modified ovarian cancer cell line as an artificial antigen presenting cell
尝试使用 HLA 修饰的卵巢癌细胞系作为人工抗原呈递细胞来鉴定肿瘤特异性细胞毒性 T 淋巴细胞识别的新抗原
- 批准号:
24659727 - 财政年份:2012
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Studies on the epigenetic mechanism of arsenic carcinogenesis on human liver cancer cell line
砷致癌人肝癌细胞系的表观遗传机制研究
- 批准号:
23790680 - 财政年份:2011
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Supramolecular Assembly of Amphiphilic Mesogenic Compounds InducingApoptosis in a Human Solid Cancer Cell Line
诱导人实体癌细胞系凋亡的两亲性介晶化合物的超分子组装
- 批准号:
23651229 - 财政年份:2011
- 资助金额:
$ 36.81万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research